Literature DB >> 25985753

Epac2-deficiency leads to more severe retinal swelling, glial reactivity and oxidative stress in transient middle cerebral artery occlusion induced ischemic retinopathy.

Jin Liu1, Patrick Ka Kit Yeung, Lu Cheng, Amy Cheuk Yin Lo, Stephen Sum Man Chung, Sookja Kim Chung.   

Abstract

Ischemia occurs in diabetic retinopathy with neuronal loss, edema, glial cell reactivity and oxidative stress. Epacs, consisting of Epac1 and Epac2, are cAMP mediators playing important roles in maintenance of endothelial barrier and neuronal functions. To investigate the roles of Epacs in the pathogenesis of ischemic retinopathy, transient middle cerebral artery occlusion (tMCAO) was performed on Epac1-deficient (Epac1 (-/-)) mice, Epac2-deficient (Epac2 (-/-)) mice, and their wild type counterparts (Epac1 (+/+) and Epac2 (+/+)). Two-hour occlusion and 22-hour reperfusion were conducted to induce ischemia/reperfusion injury to the retina. After tMCAO, the contralateral retinae displayed similar morphology between different genotypes. Neuronal loss, retinal edema and increase in immunoreactivity for aquaporin 4 (AQP4), glial fibrillary acidic protein (GFAP), peroxiredoxin 6 (Prx6) were observed in ipsilateral retinae. Epac2 (-/-) ipsilateral retinae showed more neuronal loss in retinal ganglion cell layer, increased retinal thickness and stronger immunostaining of AQP4, GFAP, and Prx6 than those of Epac2 (+/+). However, Epac1 (-/-) ipsilateral retinae displayed similar pathology as those in Epac1 (+/+) mice. Our observations suggest that Epac2-deficiency led to more severe ischemic retinopathy after retinal ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25985753     DOI: 10.1007/s11427-015-4860-1

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  10 in total

1.  A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure.

Authors:  Matthew J Hartsock; Hongkwan Cho; Lijuan Wu; Wan-Ju Chen; Junsong Gong; Elia J Duh
Journal:  J Vis Exp       Date:  2016-07-14       Impact factor: 1.355

2.  The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability.

Authors:  Carla J Ramos; Chengmao Lin; Xuwen Liu; David A Antonetti
Journal:  J Biol Chem       Date:  2017-11-20       Impact factor: 5.157

3.  Inhibiting Matrix Metalloproteinase 3 Ameliorates Neuronal Loss in the Ganglion Cell Layer of Rats in Retinal Ischemia/Reperfusion.

Authors:  Tu Hu; Qiuting You; Dan Chen; Jianbin Tong; Lei Shang; Jia Luo; Yi Qiu; Huimin Yu; Leping Zeng; Jufang Huang
Journal:  Neurochem Res       Date:  2016-01-30       Impact factor: 3.996

4.  NLRP3 Inflammasome: A Potential Target in Isoflurane Pretreatment Alleviates Stroke-Induced Retinal Injury in Diabetes.

Authors:  Hong-Bin Lin; Ying-Hui Lin; Jin-Yu Zhang; Wen-Jing Guo; Andrea Ovcjak; Zhi-Jian You; Zhong-Ping Feng; Hong-Shuo Sun; Feng-Xian Li; Hong-Fei Zhang
Journal:  Front Cell Neurosci       Date:  2021-07-08       Impact factor: 5.505

5.  Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.

Authors:  Yaping Yan; Yujing Li; Ying Fu; Li Yang; Lei Su; Kaibin Shi; Minshu Li; Qiang Liu; Aimee Borazanci; Yaou Liu; Yong He; Jeffrey L Bennett; Timothy L Vollmer; Fu-Dong Shi
Journal:  Sci China Life Sci       Date:  2016-02-26       Impact factor: 6.038

6.  Epac1 protects the retina against ischemia/reperfusion-induced neuronal and vascular damage.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

7.  Proteomics reveals ablation of PlGF increases antioxidant and neuroprotective proteins in the diabetic mouse retina.

Authors:  Madhu Sudhana Saddala; Anton Lennikov; Dennis J Grab; Guei-Sheung Liu; Shibo Tang; Hu Huang
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

Review 8.  Review: Role of cAMP signaling in diabetic retinopathy.

Authors:  Jena J Steinle
Journal:  Mol Vis       Date:  2020-05-09       Impact factor: 2.367

Review 9.  Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.

Authors:  Yunfeng Pan; Jia Liu; Jiahui Ren; Yun Luo; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2022-07-14       Impact factor: 5.988

10.  Neurodegeneration in Diabetic Retinopathy: Current Concepts and Therapeutic Implications.

Authors:  Ning-Li Wang
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.